Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Stomach Cancer, Gastro-Esophageal(GE) Junction Cancer, Gastric (Stomach) Cancer, Esophageal Cancer, Gastrointestinal Stromal Tumor (GIST)
Both
Stomach Cancer, Gastro-Esophageal(GE) Junction Cancer, Gastric (Stomach) Cancer, Esophageal Cancer, Gastrointestinal Stromal Tumor (GIST)
Trial Information
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
Inclusion Criteria:
1. Over 18 2. Diagnosed with gastric or esophageal cancer OR at anincreased hereditary risk for upper GI cancer
Exclusion Criteria:1. Under 18 2. No family or personal history of gastric or esophageal
cancer
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
p53 activity by routine pathologic analysis
Outcome Time Frame:
time of collection
Safety Issue:
No
Principal Investigator
James M Ford
Investigator Role:
Principal Investigator
Investigator Affiliation:
Stanford University
Authority:
United States: Institutional Review Board
Study ID:
GIUPR0001
NCT ID:
NCT01048281
Start Date:
August 2002
Completion Date:
December 2015
Related Keywords:
- Stomach Cancer
- Gastro-Esophageal(GE) Junction Cancer
- Gastric (Stomach) Cancer
- Esophageal Cancer
- Gastrointestinal Stromal Tumor (GIST)
- Carcinoma
- Esophageal Diseases
- Esophageal Neoplasms
- Stomach Neoplasms
- Rectal Neoplasms
- Pancreatic Neoplasms
- Duodenal Neoplasms
- Bile Duct Neoplasms
- Gastrointestinal Stromal Tumors
Name | Location |
|---|---|
| Stanford University School of Medicine | Stanford, California 94305-5317 |
